International Kidney Cancer Symposium (IKCS) 2021

The International Kidney Cancer Symposium (IKCS) 2021 took place in North America over the weekend. The following presentations are of interest to kidney cancer patients and their families and are published by UroToday: Award lecture: Dr Brian Lane gave the Andrew C. Novick Award Lecture with a talk focusing on the management of small (T1) […]

read more

ESMO 2019: IKCC global patient survey of kidney cancer patients in 43 countries

Results from the International Kidney Cancer Coalition (IKCC) global patient survey, conducted in 43 countries and almost 2,000 kidney cancer patients and carers, were presented at the European Society for Medical Oncology (ESMO) conference in Barcelona earlier this month. In this video interview, Dr Eric Jonasch, medical oncologist from the University of Texas MD Anderson […]

read more

Kidney cancer clinical trials: What you need to know

In this article, Deb Maskens, founder of Kidney Cancer Canada and board director of the International Kidney Cancer Coalition (IKCC) recommends that patients with kidney cancer should be thinking about clinical trials at every step of their journey, not just after a line of therapy has stopped working for them. Ms Maskens, an advanced kidney […]

read more

Real world evidence as a complement to clinical trials

The review article highlights the usefulness of real world evidence to add substantially to the information available to the scientific and medical communities. Randomised clinical trials have traditionally been the gold-standard for scientific evidence. However, randomised clinical trials are not able to answer all the questions necessary for clinical decision-making. Real world evidence refers to […]

read more

Patients do not feel involved in decisions about their own treatment: Results of the latest Adult Inpatient Survey by the Care Quality Commission

Results of the latest Adult Inpatient Survey by the Care Quality Commission have been published. The findings show that 44% of patients did not feel involved in decisions about their treatment. Forty-five percent also said they did not feel involved in discharge decisions, and 35% said they weren’t given enough information when leaving hospital. These results […]

read more
Showing all 5 results
  TOP